the genetic medicine and mRNA biotech is breaking the mold with a $120 million extended series B. Now, the extended round—co-led by new investors AyurMaya, an affiliate of Matrix Capital ...

JOSHUA. CHRISTINE DEVONTE, ONE OF THE EXPERTS I SPOKE TO ABOUT MOLD REMEDIATION, SAYS MOLD IS EVERYWHERE AND THERE’S A BALANCE THAT NEEDS TO BE MAINTAINED WHEN MANAGING INDOOR ENVIRONMENTS.